Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT04472260
Eligibility Criteria:
Inclusion Criteria:
* Major patient \> 18 years of age
* ARDS patients with PaO2/FiO2 ratio \< 150 at any time within 24 hours prior to the screening visit
* Hemodynamically stable patient with mean arterial pressure (MAP) \> 65 mmHg maintained without vasopressor or with norepinephrine at a dosage of less than 0.5 µg/kg/min.
* Patient having already undergone at least 1 but less than 5 PP sessions
* Patient under continuous intravenous sedation (IVSE) or not responding to simple order.
* Written consent of support person or family.
Exclusion Criteria:
* Pregnant women (positive pregnancy test during screening)
* Breastfeeding women
* Protected Majors
* Body weight greater than 198 kg (bed load limit)
* Patient with one or two lower limbs amputated at the trans tibial or upper level
* Contraindication to standing (orthopedic fracture, neurological instability with the presence of an intracranial pressure sensor or an external ventricular shunt....)
* Deep venous thrombosis of the lower limbs with curative anticoagulation for less than 48 hours
* Hemodynamic instability (MAP \< 65 mm Hg) despite the use of norepinephrine at a dosage equal or greater than 0.5 µg/kg/min.
* Person under guardianship or trusteeship
* Non-beneficiary patient of a health insurance plan
* Moribund patient
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04472260
Study Brief:
Protocol Section:
NCT04472260